Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging.
<h4>Purpose</h4>To assess the prognosis predictability of a measurable enhancing lesion using histogram parameters produced by the normalized cerebral blood volume (nCBV) and normalized apparent diffusion coefficient (nADC) after completion of standard concomitant chemoradiotherapy (CCRT...
Main Authors: | Jae Hyun Kim, Seung Hong Choi, Inseon Ryoo, Tae Jin Yun, Tae Min Kim, Se-Hoon Lee, Chul-Kee Park, Ji-Hoon Kim, Chul-Ho Sohn, Sung-Hye Park, Il Han Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113587&type=printable |
Similar Items
-
MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
by: Bo Ram Kim, et al.
Published: (2016-01-01) -
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
by: Tae Hoon Roh, et al.
Published: (2020-07-01) -
Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.
by: Seung Chai Jung, et al.
Published: (2013-01-01) -
Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
by: Sherriff, J, et al.
Published: (2013) -
Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results.
by: Takahiro Oike, et al.
Published: (2013-01-01)